CD86 and neoplasm: Studies have shown that Ganoderma lucidum polysaccharide combined with gold nanocomposites promoted the function of DCs in anti-tumor immunity, including the upregulation of MHC II, CD86, CD80, and pro-inflammatory factors transcription, as well as promoting the proliferation of CD8+ and CD4+T cells (127).